Walleye Capital
ONC

Walleye Capital’s BeOne Medicines Ltd ONC Stock Holding History

Walleye Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$85.5K Hold
300
– – ﹤0.01% 3977
2026
Q1 		$89.1K Buy
+300
New +$97.1K ﹤0.01% 3712
2024
Q2 		– Sell
-400
Closed -$62.6K – 6095
2024
Q1 		$62.6K Buy
400
+200
+100% +$32.2K ﹤0.01% 4602
2023
Q4 		$36.1K Sell
200
-100
-33% -$18.1K ﹤0.01% 4377
2023
Q3 		$54K Sell
300
-3,100
-91% -$613K ﹤0.01% 4171
2023
Q2 		$606K Buy
3,400
+3,300
+3,300% +$760K ﹤0.01% 2283
2023
Q1 		$21.6K Sell
100
-100
-50% -$24K ﹤0.01% 3392
2022
Q4 		$44K Buy
+200
New +$36.7K ﹤0.01% 2553

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Walleye Capital's ONC Position: Q2 2026 in Review

Walleye Capital reduced its BeOne Medicines Ltd (ONC) stake by 97% in Q2 2026, selling an estimated $5.99M and leaving 723 shares worth $206K. The position accounts for ﹤0.01% of the portfolio, ranked #3487.

Walleye Capital first reported a position in ONC in Q3 2023 and has held it in 10 quarters since. The position peaked at $19.8M in Q1 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Walleye Capital held 723 shares of BeOne Medicines Ltd worth $206K as of Q2 2026.
  • Walleye Capital sold 20,328 BeOne Medicines Ltd shares in Q2 2026, an estimated $5.99M.
  • BeOne Medicines Ltd made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3487 holding.
  • Walleye Capital first reported a position in BeOne Medicines Ltd in Q3 2023 and has held it in 10 quarters since.
  • Walleye Capital's BeOne Medicines Ltd position peaked at $19.8M in Q1 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.